The financial terms of the deal are robust, with Novavax receiving an upfront payment of $500 million from Sanofi.
Biopharmaceutical Company Partners With Novavax: COVID-19 Vaccine Co-commercialization
Biopharmaceutical Company Partners With…
Biopharmaceutical Company Partners With Novavax: COVID-19 Vaccine Co-commercialization
The financial terms of the deal are robust, with Novavax receiving an upfront payment of $500 million from Sanofi.